Patents Assigned to Kowa Company, Ltd.
-
Publication number: 20250057418Abstract: To provide a medical examination device having a plurality of irradiation lights that can be independently controlled while achieving downsizing, the medical examination device includes: an observation optical system that observes a subject; an illumination optical system including a slit light generation unit that generates slit light, a first light generation unit that generates first light different from the slit light, and an exterior in which a slit light irradiation port that emits the slit light and a first light irradiation port that emits the first light are formed at different positions; and a control unit that controls the illumination optical system. The first light generation unit includes a first light source disposed at a position where the first light can be emitted from the first light irradiation port.Type: ApplicationFiled: December 22, 2022Publication date: February 20, 2025Applicant: Kowa Company, Ltd.Inventor: Atsushi KAKUUCHI
-
Publication number: 20250060370Abstract: An antibody against a peptide having an amino acid sequence AVQGPEETVT QDC (expressed in single letter amino acid code) as represented by SEQ ID: NO1 corresponding to the 134- to 146-positions in human BAFF (B cell activating factor belonging to the TNF family) protein which is preferably a monoclonal antibody; a method of producing the above antibody; a medicinal composition containing the antibody; utilization of the antibody; and a method of screening an inhibitory effect or an activating effect on BAFF with the use of the antibody.Type: ApplicationFiled: August 30, 2024Publication date: February 20, 2025Applicants: KOWA COMPANY, LTD.Inventors: Tsutomu Takeuchi, Keiko Yoshimoto
-
Publication number: 20250030814Abstract: Provided is a non-statutory computer-readable medium storing thereon a medical program for implementing various kinds of processing in a terminal device used together with a medical examination device including an imaging camera, in order to play a video live and record the video, while maintaining usability of the medical examination device including the imaging camera, the video being generated by imaging by the medical examination device. The medical program, when executed, causes a processor of the terminal device to perform: playing video data live and displaying the video data on a display unit of the terminal device, the video data being captured and simultaneously transmitted in real time by the medical examination device; and controlling start/stop of recording of the video data that is currently played live based on a predetermined operation.Type: ApplicationFiled: June 16, 2022Publication date: January 23, 2025Applicant: Kowa Company, Ltd.Inventors: Takahiro SUZUKI, Atsushi KAKUUCHI
-
Patent number: 12186413Abstract: A non-cellular root canal filler comprises a tetrahydroisoquinoline compound or a pharmaceutically acceptable salt thereof, or a solvate of the compound or the salt, and a dental tissue regeneration promotion kit comprises a pretreatment agent comprising a serine protease, and the non-cellular root canal filler.Type: GrantFiled: March 27, 2020Date of Patent: January 7, 2025Assignee: KOWA COMPANY, LTD.Inventors: Misako Nakashima, Koichiro Iohara
-
Patent number: 12192610Abstract: An imaging device according to the present invention includes an illumination unit 20 containing a light source 21 for emitting illumination light 2, and a lens group 22 for irradiating an imaging object 1 with the illumination light 2 emitted from the light source 21, and an imaging unit 10 for imaging the imaging object 1. A part of the illumination light 2 is shielded by a light shielding component 40.Type: GrantFiled: June 2, 2021Date of Patent: January 7, 2025Assignee: KOWA COMPANY, LTD.Inventors: Takao Ushiyama, Eiji Takahashi
-
Publication number: 20240384984Abstract: To perform three-dimensional measurement of an object with high accuracy, a dot pattern is generated by a determination process of determining a reference position according to a rule defined by a Poisson disk sampling algorithm, a selection process of selecting one of a plurality of arrangement patterns indicating at least one or more dot arrangements, an arrangement process of arranging dots based on the arrangement pattern selected for the reference position, and an iterative process of performing the above processes a plurality of times, a projection device is controlled to project projection light including the dot pattern onto the object, an image capturing device is controlled to image-capture the object onto which the projection light is projected from two directions to acquire two captured images, parallax information is calculated about the acquire two captured images, and a three-dimensional shape of the object is specified based on the calculated parallax information.Type: ApplicationFiled: March 8, 2022Publication date: November 21, 2024Applicant: Kowa Company, Ltd.Inventor: Jun TAKEDA
-
Publication number: 20240277745Abstract: Pemafibrate, tofogliflozin, or combinations thereof for use in treating human patients with liver diseases, particularly NASH patients suffering from liver stiffness or liver fibrosis, NASH patients with lobular inflammation, NASH patients with elevated LDL-C, and NASH patients with healthy triglyceride levels.Type: ApplicationFiled: May 25, 2022Publication date: August 22, 2024Applicant: KOWA COMPANY, LTDInventors: Noboru KANETA, Ryu OSHIMA, Shona Sanchita PENDSE, Ryohei TANIGAWA
-
Publication number: 20240276960Abstract: A nest material useful in bagworm rearing is provided which can be stably supplied, is hygienic, and has high efficiency for nest building. A bagworm nest material including a bark having a specific shape and size in accordance with the stage of growth of a bagworm is also provided.Type: ApplicationFiled: June 20, 2022Publication date: August 22, 2024Applicants: NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION, KOWA COMPANY, LTD.Inventors: Ryoko ICHIKI, Taiyo YOSHIOKA, Tsunenori KAMEDA, Takayuki MATSUDA, Akimune ASANUMA
-
Patent number: 12042483Abstract: The present invention addresses the problem of providing a medicinal composition and a drug combination by which nonalcoholic fatty liver disease and nonalcoholic steatohepatitis can be prevented and/or treated. The present invention provides a combination of a peroxisome proliferator-activated receptor (PPAR) ? agonist with a sodium glucose cotransporter 2 (SGLT2) inhibitor, which is to be used for preventing and/or treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Type: GrantFiled: November 1, 2021Date of Patent: July 23, 2024Assignee: Kowa Company, Ltd.Inventors: Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka
-
Patent number: 12037708Abstract: Provided is a method developed for producing a thread bundle with high efficiency in terms of spun thread collection and without causing mechanical damage to a foothold silk thread spun by a bagworm onto a base material. After a bagworm is placed along with a solvent-soluble base material and allowed to spin the foothold silk thread onto the surface of the base material, the base material is dissolved with a solvent to separate the foothold silk thread therefrom.Type: GrantFiled: April 16, 2019Date of Patent: July 16, 2024Assignees: NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION, KOWA COMPANY, LTD.Inventors: Taiyo Yoshioka, Tsunenori Kameda, Akimune Asanuma, Keitaro Hattori, Norihiko Fukuoka
-
Publication number: 20240216272Abstract: A technique is provided for improving the stability of a halogenated isoquinoline derivative with respect to light in an aqueous composition. A pharmaceutical preparation obtained by storing an aqueous composition comprising a compound represented by Formula (1): wherein X represents a halogen atom, or a salt thereof, or a solvate of the compound or the salt thereof, in a package that blocks a ray with a wavelength of 300 to 335 nm.Type: ApplicationFiled: March 18, 2024Publication date: July 4, 2024Applicant: KOWA COMPANY, LTD.Inventors: Hiroshi ODA, Yuuki SUZUKI
-
Publication number: 20240216390Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(-)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.Type: ApplicationFiled: March 15, 2024Publication date: July 4, 2024Applicants: KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION, KOWA COMPANY, LTD.Inventors: Tatsuro Ishibashi, Shintaro Nakao, Ryoichi Arita, Ken Mizuno, Akifumi Tsuchiura
-
Publication number: 20240216342Abstract: Provided is a novel preventing and/or treating agent useful for prevention and/or treatment of carnitine deficiency, or a disease for which supplementation of carnitine may have a therapeutic effect. The present invention relates to a medicament for preventing and/or treating carnitine deficiency, or a disease for which supplementation of carnitine may have a therapeutic effect, the medicament comprising a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate thereof.Type: ApplicationFiled: April 27, 2022Publication date: July 4, 2024Applicant: KOWA COMPANY, LTD.Inventors: Ryohei TANIGAWA, Ayumi SAITO, Kaho IKEGAMI
-
Publication number: 20240197688Abstract: The present invention addresses the problem of providing a pharmaceutical composition/drug combination which makes it possible to prevent and/or treat dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events. The present invention provides a combination of a peroxisome proliferator-activated receptor (PPAR) ? agonist and an ATP citrate lyase (ACL) inhibitor for preventing and/or treating dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events.Type: ApplicationFiled: April 19, 2022Publication date: June 20, 2024Applicant: KOWA COMPANY, LTD.Inventors: Noriyuki INOUE, Kenji SAITO, Toshiaki TAKIZAWA
-
Patent number: 11998274Abstract: An ophthalmic photographing apparatus enables easy detection of a pupil diameter. The ophthalmic photographing apparatus is provided with an anterior ocular segment illumination unit for illuminating an anterior ocular segment of a subject eye with invisible light, an imaging element that is sensitive to at least invisible light and captures an image of the subject eye, and a processing unit for processing the image captured by the imaging element. When an image of an index projected onto the anterior ocular segment satisfies a predetermined condition, the processing unit starts detection of a pupil diameter of the subject eye by using the image on the imaging element formed by invisible light reflected from the anterior ocular segment.Type: GrantFiled: August 7, 2019Date of Patent: June 4, 2024Assignee: Kowa Company, Ltd.Inventors: Kazunori Matsumura, Akio Kawakami
-
Patent number: 11969487Abstract: A non-cellular dental tissue regeneration promoting kit is provided that makes effective dental tissue regeneration possible without transplantation of autologous or allogeneic stem cells or components derived from stem cells. The kit comprises: a pretreatment agent comprising a serine protease; and a non-cellular root canal filling material, the non-cellular root canal filling material comprising: a regeneration promoting compound including at least one of a CCR3 antagonist, a CCL11 neutralizing antibody, and an ALK5 inhibitor; and an extracellular matrix. The kit is preferably used for middle-aged or elderly individuals.Type: GrantFiled: September 21, 2018Date of Patent: April 30, 2024Assignee: Kowa Company, Ltd.Inventors: Misako Nakashima, Koichiro Iohara
-
Publication number: 20240092953Abstract: The present invention provides a novel copolymer available for a drug delivery technique. More particularly, a novel copolymer for a drug delivery carrier targeting a tumor is provided. The present invention relates to a copolymer comprising structural units represented by the following formulas (A), (B), and (C): wherein R1, R2, and R3 are the same or different and represent a hydrogen atom or a C1-3 alkyl group, R4 represents a C1-3 alkyl group, R5 represents a hydrogen atom, a C1-18 alkyl group, a 3- to 8-membered cycloalkyl group optionally having a substituent, an adamantyl group, a C6-18 aryl group optionally having a substituent, or a 5- to 10-membered heteroaryl group optionally having a substituent, X1, X2, and X3 are the same or different and represent an oxygen atom, a sulfur atom, or N—R7, R6 represents a hydrogen atom, a leaving group, or a linker, R7 represents a hydrogen atom or a C1-3 alkyl group, m represents an integer of 1 to 100, and n represents an integer of 0 to 3.Type: ApplicationFiled: February 7, 2022Publication date: March 21, 2024Applicant: KOWA COMPANY, LTD.Inventors: Ryo KANAYA, Kenichi SUZUKI, Tsukasa CHIDA, Nobuhiro FUJIMAKI, Marina ECHIGO, Seiji MIURA
-
Publication number: 20240085655Abstract: According to one or more embodiments of the disclosure, a lens barrel includes an operation member and a knob. The operation member is disposed to be rotatable in a circumferential direction with respect to a lens barrel body. The knob is restricting and fixing rotation of the operation member in the circumferential direction. The lens barrel further includes a knob falling-off prevention member capable of switching between a first state of making the knob detachable from the lens barrel body and a second state of making the knob non-detachable from the lens barrel body.Type: ApplicationFiled: January 27, 2022Publication date: March 14, 2024Applicant: Kowa Company, Ltd.Inventors: Jun TAKAYAMA, Syuichi TOMINAGA
-
Patent number: 11926927Abstract: Developed and provided is a method of collecting a large amount of high-quality bagworm silk threads having no contaminant from bagworm nests in a convenient manner and at low cost. The habit of bagworms is utilized to allow a bagworm to build a nest using solvent-soluble substances or thermally meltable substances as nest materials, followed by dissolving or melting the nest materials to separate the nest material from the bagworm silk threads, whereby only pure bagworm silk threads constituting the bagworm nest can be obtained.Type: GrantFiled: December 18, 2018Date of Patent: March 12, 2024Assignees: NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION, KOWA COMPANY, LTD.Inventors: Taiyo Yoshioka, Tsunenori Kameda, Akimune Asanuma, Hironori Sassa
-
Patent number: D1016875Type: GrantFiled: March 4, 2022Date of Patent: March 5, 2024Assignee: KOWA COMPANY, LTD.Inventors: Kentaro Kaneko, Katsuyuki Masada